missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
Danoprevir, MedChemExpress
Description
Danoprevir (ITMN-191) is an orally active NS3/4A protease inhibitor for hepatitis C virus (HCV) with an IC50 of 0.29 nM and is selective for NS3/4A over a panel of 53 proteases (IC50 higher than 10 μM). Danoprevir (ITMN-191) inhibits HCV genotypes 1a, 1b, 4, 5, and 6 (IC50s=0.2-0.4 nM) as well as 2b and 3a (IC50s=1.6, 3.5 nM). Danoprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 0.05 μM.
Specifications
Specifications
| Kemisk navn eller materiale | Danoprevir |
| CAS | 850876-88-9 |
| Farve | White |
| Renhedsgrad noter | Research |
| Molekylær formel | C35H46FN5O9S |
| Mængde | 10 mg |
| Synonym | ITMN-191 R7227 RO5190591 RG7227 |
| Opløselighedsinformation | DMSO : ≥ 100 mg/mL (136.64 mM) |
| SMIL | O=S(NC([C@@]1(NC([C@]2([H])C[C@@H](OC(N3CC4=C(C3)C=CC=C4F)=O)CN2C5=O)=O)C[C@]1(/C=C/CCCCC[C@@H]5NC(OC(C)(C)C)=O)[H])=O)(C6CC6)=O |
| Molekylvægt (g/mol) | 731.83 |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?